• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    91.53 Up 3.35(3.80%) Dec 26, 4:00PM EST
    |After Hours : 91.54 Up 0.01 (0.01%) Dec 26, 4:44PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 176,847   191,787   151,552   146,873  
    Cost of Revenue29,920  31,210  22,816  24,621  
    Gross Profit 146,927   160,577   128,736   122,252  
    Operating Expenses
    Research Development125,686  107,702  86,166  97,312  
    Selling General and Administrative74,366  68,089  60,069  71,809  
    Non Recurring -   -   -   -  
    Others3,172  3,668  8,957  5,441  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 11,203   (18,882) (26,456) (52,310)
    Income from Continuing Operations
    Total Other Income/Expenses Net68,861  914  1,276  966  
    Earnings Before Interest And Taxes12,339  (18,507)(25,518)(51,782)
    Interest Expense9,118  9,221  9,106  7,593  
    Income Before Tax3,221  (27,728)(34,624)(59,375)
    Income Tax Expense(4,224)5,774  3,491  2,615  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops7,220  (34,041)(38,453)(62,428)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 7,445   (33,502) (38,115) (61,990)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 7,445   (33,502) (38,115) (61,990)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.